Immatics Capex To Revenue vs Ev To Sales Analysis

IMTX Stock

USD 7.59 0.01 0.13%

Immatics financial indicator trend analysis is infinitely more than just investigating Immatics NV recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Immatics NV is a good investment. Please check the relationship between Immatics Capex To Revenue and its Ev To Sales accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immatics NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

Capex To Revenue vs Ev To Sales

Capex To Revenue vs Ev To Sales Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Immatics NV Capex To Revenue account and Ev To Sales. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between Immatics' Capex To Revenue and Ev To Sales is -0.49. Overlapping area represents the amount of variation of Capex To Revenue that can explain the historical movement of Ev To Sales in the same time period over historical financial statements of Immatics NV, assuming nothing else is changed. The correlation between historical values of Immatics' Capex To Revenue and Ev To Sales is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capex To Revenue of Immatics NV are associated (or correlated) with its Ev To Sales. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Ev To Sales has no effect on the direction of Capex To Revenue i.e., Immatics' Capex To Revenue and Ev To Sales go up and down completely randomly.

Correlation Coefficient

-0.49

Relationship Direction	Negative
Relationship Strength	Very Weak

View All Relationships

Capex To Revenue

The ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets.

Ev To Sales

The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.

Most indicators from Immatics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Immatics NV current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immatics NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

Sales General And Administrative To Revenue is likely to rise to 1.03 in 2024, whereas Tax Provision is likely to drop 0.00 in 2024.

	2021	2022	2023	2024 (projected)
Interest Income	5.7M	2.5M	13.8M	14.5M
Net Interest Income	3.9M	1.4M	13.0M	13.7M

Interest Income Net Interest Income

Immatics fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Retained Earnings	Accounts Payable	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Capital Surpluse	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Property Plant Equipment	Short Long Term Debt Total	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Cash	Non Current Assets Total	Non Currrent Assets Other
Total Assets		0.47	0.89	0.52	-0.01	0.92	-0.81	0.63	0.84	0.95	0.77	0.62	-0.68	0.9	0.88	0.83	0.97	-0.63	0.91	0.93	0.83	0.74	-0.77	0.84	0.94	0.7
Other Current Liab	0.47		0.47	0.49	-0.73	0.44	-0.47	0.36	0.38	0.33	0.12	0.67	-0.1	0.49	0.4	0.23	0.37	-0.32	0.53	0.6	0.51	0.51	-0.19	0.24	0.62	0.32
Total Current Liabilities	0.89	0.47		0.11	0.19	0.83	-0.9	0.6	0.76	0.95	0.68	0.61	-0.88	0.88	0.95	0.96	0.94	-0.74	0.97	0.94	0.84	0.65	-0.74	0.8	0.93	0.49
Total Stockholder Equity	0.52	0.49	0.11		-0.7	0.45	-0.1	0.33	0.42	0.23	0.34	0.42	0.25	0.35	0.12	-0.06	0.33	0.03	0.22	0.34	0.29	0.52	-0.19	0.24	0.4	0.63
Other Liab	-0.01	-0.73	0.19	-0.7		-0.01	-0.15	-0.08	-0.03	0.26	0.21	-0.38	-0.58	0.01	0.24	0.44	0.17	-0.24	0.1	-0.03	-0.02	-0.24	-0.26	0.25	-0.08	-0.22
Net Tangible Assets	0.92	0.44	0.83	0.45	-0.01		-0.89	0.5	0.91	0.89	0.65	0.58	-0.65	0.98	0.85	0.78	0.91	-0.73	0.84	0.91	0.93	0.64	-0.86	0.84	0.87	0.64
Retained Earnings	-0.81	-0.47	-0.9	-0.1	-0.15	-0.89		-0.32	-0.7	-0.89	-0.5	-0.4	0.84	-0.9	-0.95	-0.88	-0.87	0.93	-0.91	-0.92	-0.87	-0.42	0.87	-0.87	-0.82	-0.3
Accounts Payable	0.63	0.36	0.6	0.33	-0.08	0.5	-0.32		0.71	0.5	0.84	0.87	-0.27	0.58	0.36	0.52	0.54	0.03	0.46	0.49	0.65	0.97	-0.36	0.38	0.75	0.6
Other Assets	0.84	0.38	0.76	0.42	-0.03	0.91	-0.7	0.71		0.77	0.69	0.78	-0.51	0.93	0.67	0.7	0.8	-0.44	0.7	0.8	0.9	0.79	-0.67	0.62	0.82	0.8
Cash And Short Term Investments	0.95	0.33	0.95	0.23	0.26	0.89	-0.89	0.5	0.77		0.7	0.47	-0.88	0.88	0.97	0.95	0.99	-0.78	0.96	0.94	0.8	0.57	-0.81	0.88	0.89	0.56
Net Receivables	0.77	0.12	0.68	0.34	0.21	0.65	-0.5	0.84	0.69	0.7		0.55	-0.49	0.66	0.57	0.68	0.73	-0.27	0.57	0.56	0.69	0.83	-0.7	0.74	0.79	0.47
Common Stock Shares Outstanding	0.62	0.67	0.61	0.42	-0.38	0.58	-0.4	0.87	0.78	0.47	0.55		-0.2	0.67	0.39	0.44	0.52	-0.06	0.52	0.61	0.7	0.9	-0.25	0.24	0.75	0.71
Capital Surpluse	-0.68	-0.1	-0.88	0.25	-0.58	-0.65	0.84	-0.27	-0.51	-0.88	-0.49	-0.2		-0.68	-0.92	-0.96	-0.83	0.82	-0.86	-0.77	-0.61	-0.26	0.69	-0.75	-0.67	-0.22
Other Current Assets	0.9	0.49	0.88	0.35	0.01	0.98	-0.9	0.58	0.93	0.88	0.66	0.67	-0.68		0.85	0.82	0.9	-0.71	0.85	0.92	0.97	0.69	-0.84	0.81	0.9	0.61
Other Stockholder Equity	0.88	0.4	0.95	0.12	0.24	0.85	-0.95	0.36	0.67	0.97	0.57	0.39	-0.92	0.85		0.94	0.95	-0.89	0.98	0.95	0.78	0.45	-0.81	0.88	0.85	0.4
Total Liab	0.83	0.23	0.96	-0.06	0.44	0.78	-0.88	0.52	0.7	0.95	0.68	0.44	-0.96	0.82	0.94		0.92	-0.76	0.92	0.86	0.77	0.52	-0.77	0.82	0.83	0.4
Total Current Assets	0.97	0.37	0.94	0.33	0.17	0.91	-0.87	0.54	0.8	0.99	0.73	0.52	-0.83	0.9	0.95	0.92		-0.74	0.95	0.95	0.81	0.63	-0.8	0.87	0.91	0.62
Common Stock	-0.63	-0.32	-0.74	0.03	-0.24	-0.73	0.93	0.03	-0.44	-0.78	-0.27	-0.06	0.82	-0.71	-0.89	-0.76	-0.74		-0.81	-0.78	-0.65	-0.08	0.8	-0.82	-0.6	-0.07
Property Plant Equipment	0.91	0.53	0.97	0.22	0.1	0.84	-0.91	0.46	0.7	0.96	0.57	0.52	-0.86	0.85	0.98	0.92	0.95	-0.81		0.98	0.78	0.55	-0.71	0.8	0.9	0.51
Short Long Term Debt Total	0.93	0.6	0.94	0.34	-0.03	0.91	-0.92	0.49	0.8	0.94	0.56	0.61	-0.77	0.92	0.95	0.86	0.95	-0.78	0.98		0.84	0.6	-0.72	0.78	0.92	0.61
Property Plant And Equipment Net	0.83	0.51	0.84	0.29	-0.02	0.93	-0.87	0.65	0.9	0.8	0.69	0.7	-0.61	0.97	0.78	0.77	0.81	-0.65	0.78	0.84		0.73	-0.85	0.79	0.89	0.49
Current Deferred Revenue	0.74	0.51	0.65	0.52	-0.24	0.64	-0.42	0.97	0.79	0.57	0.83	0.9	-0.26	0.69	0.45	0.52	0.63	-0.08	0.55	0.6	0.73		-0.45	0.48	0.83	0.67
Net Debt	-0.77	-0.19	-0.74	-0.19	-0.26	-0.86	0.87	-0.36	-0.67	-0.81	-0.7	-0.25	0.69	-0.84	-0.81	-0.77	-0.8	0.8	-0.71	-0.72	-0.85	-0.45		-0.97	-0.74	-0.21
Cash	0.84	0.24	0.8	0.24	0.25	0.84	-0.87	0.38	0.62	0.88	0.74	0.24	-0.75	0.81	0.88	0.82	0.87	-0.82	0.8	0.78	0.79	0.48	-0.97		0.81	0.25
Non Current Assets Total	0.94	0.62	0.93	0.4	-0.08	0.87	-0.82	0.75	0.82	0.89	0.79	0.75	-0.67	0.9	0.85	0.83	0.91	-0.6	0.9	0.92	0.89	0.83	-0.74	0.81		0.58
Non Currrent Assets Other	0.7	0.32	0.49	0.63	-0.22	0.64	-0.3	0.6	0.8	0.56	0.47	0.71	-0.22	0.61	0.4	0.4	0.62	-0.07	0.51	0.61	0.49	0.67	-0.21	0.25	0.58

Click cells to compare fundamentals

Immatics Account Relationship Matchups

Immatics fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	134.3M	254.6M	174.6M	407.8M	510.0M	298.3M
Other Current Liab	3.4M	8.4M	37.3M	27.6M	38.0M	25.0M
Total Current Liabilities	69.3M	60.6M	95.1M	106.5M	156.6M	94.4M
Total Stockholder Equity	(41.9M)	104.3M	24.1M	213.2M	225.1M	122.1M
Net Tangible Assets	(42.9M)	86.5M	22.7M	211.5M	243.3M	255.4M
Retained Earnings	(233.2M)	(462.3M)	(537.8M)	(500.3M)	(597.3M)	(627.2M)
Accounts Payable	4.9M	2.6M	3.0M	4.0M	7.7M	4.8M
Other Assets	1.3M	724K	636K	2.5M	2.9M	3.1M
Cash And Short Term Investments	119.4M	232.0M	145.1M	362.2M	425.9M	235.7M
Net Receivables	2.7M	2.9M	682K	2.1M	5.7M	2.9M
Other Current Assets	665K	4.1M	4.7M	12.8M	17.7M	18.6M
Other Stockholder Equity	190.9M	538.7M	565.2M	714.2M	823.2M	519.1M
Total Liab	175.1M	150.4M	150.6M	194.7M	284.9M	176.1M
Total Current Assets	124M	239.0M	152.2M	377.2M	449.4M	256.1M
Property Plant Equipment	8.0M	14.0M	20.5M	26.5M	30.5M	16.1M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for Immatics Stock Analysis

When running Immatics' price analysis, check to measure Immatics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immatics is operating at the current time. Most of Immatics' value examination focuses on studying past and present price action to predict the probability of Immatics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immatics' price. Additionally, you may evaluate how the addition of Immatics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Immatics Capex To Revenue vs Ev To Sales Analysis

Capex To Revenue vs Ev To Sales

Capex To Revenue vs Ev To Sales Correlation Analysis

Correlation Coefficient

Capex To Revenue

Ev To Sales

Immatics fundamental ratios Correlations

Immatics Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Immatics fundamental ratios Accounts

Also Currently Popular

Additional Tools for Immatics Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 0.99	Cash And Short Term Investments
Other Current Assets	+ 0.98	Net Tangible Assets
Property Plant Equipment	+ 0.98	Other Stockholder Equity
Short Long Term Debt Total	+ 0.98	Property Plant Equipment
Total Current Assets	+ 0.97	Total Assets
Property Plant Equipment	+ 0.97	Total Current Liabilities

Cash	- 0.97	Net Debt
Total Liab	- 0.96	Capital Surpluse
Other Stockholder Equity	- 0.95	Retained Earnings
Other Stockholder Equity	- 0.92	Capital Surpluse
Short Long Term Debt Total	- 0.92	Retained Earnings
Property Plant Equipment	- 0.91	Retained Earnings